drugset / Trial / NCT00733551
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety, tolerability and exposure of repeat escalating oral doses of GSK962040.
Timeline
- Start
- 2008-09-23
- Primary completion
- 2009-07-20
- Completion
- 2009-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | camicinal | Small molecule | 10 mg | Oral |
| Subject | camicinal | Small molecule | 30 mg | Oral |
| Subject | camicinal | Small molecule | 100 mg | Oral |